The value of cure associated with treating treatment‐naïve chronic hepatitis C genotype 1: Are the new all‐oral regimens good value to society?
Zobair M. Younossi; Haesuk Park; Douglas Dieterich; Sammy Saab; Aijaz Ahmed; Stuart C. Gordon
Author Information: Center for Liver Disease
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.